» Articles » PMID: 16301828

Establishment and Characterization of a Novel Polarized MDCK Epithelial Cellular Model for CFTR Studies

Overview
Date 2005 Nov 23
PMID 16301828
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

F508del is the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsible for the genetic disease Cystic Fibrosis (CF). It results in a major failure of CFTR to traffic to the apical membrane of epithelial cells, where it should function as a chloride (Cl-) channel. Most studies on localization, processing and cellular trafficking of wild-type (wt) and F508del-CFTR have been performed in non-epithelial cells. Notwithstanding, polarized epithelial cells possess distinctly organized and regulated membrane trafficking pathways. We have used Madin-Darby canine kidney (MDCK) type II cells (proximal tubular cells which do not express endogenous CFTR) to generate novel epithelial, polarized cellular models stably expressing wt- or F508del-CFTR through transduction with recombinant lentiviral vectors. Characterization of these cell lines shows that wt-CFTR is correctly processed and apically localized, producing a cAMP-activated Cl- conductance. In contrast, F508del-CFTR is mostly detected in itsimmature form, localized intracellularly and producing only residual Cl- conductance. These novel cell lines constitute bona fide models and significantly improved resources to investigate the molecular mechanisms of polarized membrane traffic of wt- and F508del-CFTR in the same cellular background. They are also useful to identify/validate novel therapeutic compounds for CF.

Citing Articles

TMEM16A drives renal cyst growth by augmenting Ca signaling in M1 cells.

Cabrita I, Buchholz B, Schreiber R, Kunzelmann K J Mol Med (Berl). 2020; 98(5):659-671.

PMID: 32185407 PMC: 7220898. DOI: 10.1007/s00109-020-01894-y.


Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.

Sharma N, Evans T, Pellicore M, Davis E, Aksit M, McCague A PLoS Genet. 2018; 14(11):e1007723.

PMID: 30444886 PMC: 6267994. DOI: 10.1371/journal.pgen.1007723.


Folding and rescue of a cystic fibrosis transmembrane conductance regulator trafficking mutant identified using human-murine chimeric proteins.

Da Paula A, Sousa M, Xu Z, Dawson E, Boyd A, Sheppard D J Biol Chem. 2010; 285(35):27033-27044.

PMID: 20551307 PMC: 2930703. DOI: 10.1074/jbc.M110.120352.


Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa.

Davidson A, Millar I, Urquhart J, Burgess-Mullan R, Shweikh Y, Parry N Am J Hum Genet. 2009; 85(5):581-92.

PMID: 19853238 PMC: 2775838. DOI: 10.1016/j.ajhg.2009.09.015.


Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Krasnov K, Tzetis M, Cheng J, Guggino W, Cutting G Hum Mutat. 2008; 29(11):1364-72.

PMID: 18951463 PMC: 2785447. DOI: 10.1002/humu.20866.